Otsuka Pharmaceutical Co., Ltd.

Corporate
June 26, 2008

Otsuka Pharmaceutical Co., Ltd. Announces the Appointment of New President

Tokyo, Japan -- Otsuka Pharmaceutical Co., Ltd. (Head office: Chiyoda-ku, Tokyo) today announced that the board of directors passed a resolution at its meeting held on June 25, 2008 to appoint Mr. Taro Iwamoto as the new President and Representative Director of Otsuka Pharmaceutical Co., Ltd.

Mr. Iwamoto succeeds Mr. Tatsuo Higuchi, who has held the office of President and Representative Director since June, 2000. During his 8-year tenure, Mr. Higuchi led Otsuka Pharmaceutical's overseas expansion and strengthened the company's global operations, reinforcing Otsuka Pharmaceutical's position as the core company of the Otsuka Pharmaceutical Group. As Otsuka Pharmaceutical's president and representative director, Mr. Iwamoto, who combines strong leadership with expertise both in international business development and in global R&D, will steer Otsuka Pharmaceutical towards further global expansion of both our pharmaceutical and consumer products businesses in line with our objective to become a global value-creating company.

Biography of Newly Appointed President

Name Taro Iwamoto
Place of Birth Shizuoka prefecture
Date of Birth August 14, 1960
BiographyNovember, 1994 Joined Otsuka Pharmaceutical Co., Ltd.
October, 1998 GPL (aripiprazole), Development Department,
Headquarters of New Drug Evaluation and Development
April, 2004 Operating Officer, GPL (aripiprazole), Development Department,
Headquarters of New Drug Evaluation and Development
February, 2007 Senior Operating Officer, Pharmaceutical Business Division (OPDC)
June, 2007 Executive Operating Officer, Associate General Manager,
Pharmaceutical Business Division (OPDC)
June, 2008 President and Representative Director
  • GPL: Global Project Leader
  • OAPI: Otsuka America Pharmaceutical Inc.
  • OPDC: Otsuka Pharmaceutical Development and Commercialization Inc.